Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Arvinas and Pfizer transfer newly approved breast cancer drug to Rigel Pharmaceuticals

13/05/2026 Published by vivi

Arvinas and its partner Pfizer have reached a long-awaited licensing agreement for Veppanu, the first-of-its-kind "PROTAC" breast cancer medicine. According... Read more

Tags: #Global Trends

Bristol Myers Squibb and Hengrui Pharma forge $15.2B alliance to accelerate multi-target R&D

13/05/2026 Published by vivi

Bristol Myers Squibb (BMS) and Hengrui Pharma have launched a global strategic collaboration and licensing agreement. The partnership encompasses 13... Read more

Category: Uncategorized

Tags: #Global Trends

Boehringer Ingelheim strikes €400M+ deal with Immunitas to expand immunology pipeline

13/05/2026 Published by vivi

Boehringer Ingelheim has entered into a global licensing agreement with Immunitas Therapeutics for a preclinical antibody program. This transaction underscores... Read more

Category: Uncategorized

Tags: #Global Trends

Leading Vietnamese pharmaceutical firms transition to foreign control

13/05/2026 Published by vivi

The Vietnamese pharmaceutical landscape is experiencing a significant influx of international capital, with nearly all top-tier firms by market capitalization... Read more

Category: Uncategorized

Tags: #M&A

Ministry of Health proposes a unified focal point for food safety management

13/05/2026 Published by vivi

On the afternoon of May 12, 2026, Minister of Health Dao Hong Lan chaired a meeting with relevant ministries and... Read more

Category: Uncategorized

Tags: #Vietnam

HIU completes hospital-university model: President Pham Van Linh appointed as Hospital Director

13/05/2026 Published by vivi

Hong Bang International University (HIU) has officially announced the appointment of Prof. Dr. Pham Van Linh as the Director of... Read more

Category: Uncategorized

Tags: #Vietnam

Bristol Myers Squibb and Hengrui Pharma forge $15B alliance to accelerate global R&D

13/05/2026 Published by vivi

Bristol Myers Squibb (BMS) has announced a major collaboration and licensing agreement with China-based Hengrui Pharma. The deal covers 13... Read more

Category: Uncategorized

Tags: #Global Trends

Livzon Group completes acquisition, securing majority control of Imexpharm Pharmaceutical

12/05/2026 Published by vivi

The Vietnamese pharmaceutical landscape has seen a significant shift in corporate ownership at Imexpharm Pharmaceutical JSC (Ticker: IMP). As of... Read more

Category: Uncategorized

Tags: #M&A